首页> 美国卫生研究院文献>Oncotarget >Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis
【2h】

Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis

机译:肿瘤相关巨噬细胞浸润对非小细胞肺癌的预后影响:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor-associated macrophages (TAMs) are important components of cancer microenvironment. In the present study, we searched PubMed, Embase, Cochrane library and Web of Science to perform a meta-analysis of 20 studies including a total of 2,572 non-small cell lung cancer (NSCLC) patients, in order to determine the association between TAMs and NSCLC prognosis. The combined hazard ratio (HR) of 9 studies showed that the density of total CD68+ TAMs in the tumor islet and stroma was not associated with overall survival (OS) of the patients. However, the pooled HR of 4 studies showed that high density of CD68+ TAMs in the tumor islet predicted better OS, while the pooled HR of 6 studies showed that high density of CD68+ TAMs in the tumor stroma was associated with poor OS. A high islet/stroma ratio of CD68+ TAMs was associated with better OS. A high density of M1 TAMs in the tumor islet was associated with better OS, while a high density of M2 TAMs in the tumor stroma predicted poor OS. These findings suggest that, although the density of total CD68+ TAMs is not associated with OS, the localization and M1/M2 polarization of TAMs are potential prognostic predictors of NSCLC.
机译:肿瘤相关巨噬细胞(TAM)是癌症微环境的重要组成部分。在本研究中,我们搜索PubMed,Embase,Cochrane库和Web of Science进行了20项研究的荟萃分析,包括总共2,572名非小细胞肺癌(NSCLC)患者,以确定TAM之间的关联和NSCLC的预后。 9项研究的综合危险比(HR)表明,肿瘤胰岛和间质中总CD68 + TAM的密度与患者的总生存(OS)无关。但是,4项研究的合并HR显示肿瘤胰岛中高密度的CD68 + TAMs预测更好的OS,而6项研究的合并HR显示高密度的CD68 + 肿瘤基质中的TAM与OS差有关。较高的胰岛/基质比率的CD68 + TAM与更好的OS有关。胰岛中M1 TAM的高密度与较好的OS相关,而肿瘤基质中M2 TAM的高密度预示着较差的OS。这些发现表明,尽管总CD68 + TAM的密度与OS不相关,但TAM的定位和M1 / M2极化是NSCLC的潜在预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号